Global Longlife Hospital re-appoints Manasvi Manu Thapar as Independent Director

1 min read     Updated on 30 May 2026, 04:21 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Global Longlife Hospital and Research Limited's Board has approved the re-appointment of Mr. Manasvi Manu Thapar as Independent Director for a second term of five years, effective from September 10, 2026, to September 09, 2031, pending shareholder approval.

powered bylight_fuzz_icon
41683888

*this image is generated using AI for illustrative purposes only.

Global Longlife Hospital and Research Limited has approved the re-appointment of Mr. Manasvi Manu Thapar as Independent Director for a second term of five years, subject to shareholder approval. The decision was taken during a Board meeting held on May 30, 2026. The new term is scheduled to commence on September 10, 2026, and will conclude on September 09, 2031.

The Board's decision follows the recommendation of the nomination and remuneration committee. The re-appointment is pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has disclosed that Mr. Thapar is not related to any other director on the Board and is not debarred from holding the position of director by any SEBI order.

Mr. Manasvi Manu Thapar holds a B.A. L.L.B (Hons.) degree, a five-year integrated programme from Nirma University in Ahmedabad. He currently runs his own professional practice under the name Candour Legal and brings 10 years of experience to the role.

Details of Appointment

Sr. No. Details Information
1. Reason for change Re-appointment of Mr. Manasvi Manu Thapar as Independent Director for second term.
2. Date of Appointment Saturday, May 30, 2026.
3. Term of Appointment Five consecutive financial years commencing from September 10, 2026 to September 09, 2031.
4. Brief Profile B.A. L.L.B (Hons.) from Nirma University; 10 years of experience; runs Candour Legal firm.
5. Disclosure of relationships Not related to any director of the company.

Historical Stock Returns for Global Longlife Hospital & Research

1 Day5 Days1 Month6 Months1 Year5 Years
-4.74%+0.58%-4.89%-30.35%-61.03%-91.08%

How will Mr. Thapar's legal expertise influence the company's governance and compliance strategies over the next five years?

What strategic initiatives does the company plan to prioritize during Mr. Thapar's second term as Independent Director?

How might shareholder sentiment impact the approval process for Mr. Thapar's re-appointment?

Global Longlife Hospital & Research
View Company Insights
View All News
like20
dislike

Global Longlife Hospital appoints secretarial auditor for FY27

1 min read     Updated on 30 May 2026, 04:08 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Global Longlife Hospital and Research Limited appointed M/s Insiya Nalawala and Associates as its Secretarial Auditor for FY 2026-2027 during a board meeting on May 30, 2026. The firm, holding COP No. 22786, will conduct the audit for the financial year. The appointment complies with SEBI LODR Regulations.

powered bylight_fuzz_icon
41683094

*this image is generated using AI for illustrative purposes only.

global longlife hospital & research has appointed M/s Insiya Nalawala and Associates as its Secretarial Auditor for FY 2026-2027. The decision was taken during a board meeting held on May 30, 2026. The appointment ensures compliance with secretarial audit requirements for the upcoming financial year.

The Board of Directors approved the appointment of M/s Insiya Nalawala and Associates, Company Secretaries, to conduct the secretarial audit. The firm holds a Certificate of Practice (COP) No. 22786 and Peer Review No. 5443/2024. The appointment is effective from May 30, 2026, and covers the audit for FY 2026-2027.

M/s Insiya Nalawala and Associates is a firm of Practicing Company Secretaries with experience in Company Law, Securities Law, and Labour Law. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The meeting commenced at 01:00 P.M. and concluded at 02:30 P.M. on May 30, 2026. Dhruv Sureshkumar Jani, Managing Director, signed the disclosure on behalf of the company.

Appointment Details

Sr. No. Details Information
1. Reason for change M/s. Insiya Nalawala & Associates appointed as Secretarial Auditor for FY 2026-2027.
2. Date of Appointment Saturday, May 30, 2026.
3. Term of Appointment Secretarial auditor of the company for FY 2026-2027.
4. Brief Profile M/s. Insiya Nalawala & Associates has experience in Company Law, Securities Law, and Labour Law.

Historical Stock Returns for Global Longlife Hospital & Research

1 Day5 Days1 Month6 Months1 Year5 Years
-4.74%+0.58%-4.89%-30.35%-61.03%-91.08%

What factors led to the selection of M/s Insiya Nalawala and Associates over the previous auditor?

How will this appointment impact the company's compliance efficiency and governance standards?

Are there any anticipated changes in the company's regulatory focus or reporting practices for FY 2026-2027?

Global Longlife Hospital & Research
View Company Insights
View All News
like20
dislike

More News on Global Longlife Hospital & Research

1 Year Returns:-61.03%